Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1121-1123

  Hubacek, Jaroslav A ^a,b   Bloudíčková, Silvie ^a   Bohuslavová, Romana ^a,b   Táborský, Petr ^a   Polakovič, Vladimír ^a   Sazamová, Magdaléna ^a   Svítilová, Eva ^a   Vlasák, Jičí ^a   Sojková, Iva ^a   Ryba, Miroslav ^a   Knetl, Petr ^a   Ullrych, Martin ^a   Drahozal, Radim ^a   Pavuková, Veronika ^a   Pavlíková, Beata ^a   Fischlová, Drahomíra ^a   Mokrejšová, Magdaléna ^a   Chmelíčková, Hana ^a   Pauchová, Eva ^a   Vyskočil, Pavel ^a   Nýdlová, Zuzana ^a   Kopenec, Jaroslav ^a   Fixa, Petr ^a   Hajný, Jan ^a   Bubeníček, Petr ^a   Syrovátka, Petr ^a   Zahálková, Jana ^a   Šurel, Stanislav ^a   Hobzek, Zdeněk ^a   Hrubý, Aleš ^a   Suchanová, Jana ^a   Vaňková, Světlana ^a   Brabcová, Jana ^a   Viklický, Ondřej ^b   more..

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Ctr for Exp Cardiovasc Research   (Czech Republic)

Author keywords

Cholesterol; Ghrelin; Polymorphism; Renal failure

Indexed keywords

ALBUMIN; CHOLESTEROL; GHRELIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENOTYPE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; ARGININE; BODY MASS INDEX; CHOLESTEROL; DIALYSIS; FEMALE; GHRELIN; GLUTAMINE; HETEROZYGOTE; HUMANS; KIDNEY FAILURE; LEUCINE; MALE; METHIONINE; RENAL DIALYSIS; VARIATION (GENETICS);

EID: 34548599888     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.141     Document Type: Article

References (11)

1. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17(Suppl 11):28-31.
2. Pecoits-Filho R, Nordfors L, Lindholm B, Hoff CM, Schalling M, Stenvinkel P. Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype. Kidney Int Suppl 2003;84:S162-7.
3. Nordfors L, Lindholm B, Stenvinkel P. End-stage renal disease - not an equal opportunity disease: the role of genetic polymorphisms. J Intern Med 2005;258:1-12.
4. Kojima M, Hosoda H, Date Y, Nakayato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
5. Ukkola O, Pöykkö S. Ghrelin, growth and obesity. Ann Med 2002;34:102-8.
6. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Changon M, Sjostrom L, Bouchard C. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 2001;86:3996-9.
7. Hinney A, Hoch A, Geller F, Schäfer H, Siegfried W, Goldschmidt H, et al. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 2002;87:2716-9.
8. Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Peteiro J, Garcia-Naveiro R, Garcia-Buela J. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 2004;19:2095-100.
9. Jarkovska Z, Rosicka M, Krsek M, Sulkova S, Haluzik M, Justova V, et al. Plasma ghrelin levels in patients with end-stage renal disease. Physiol Res 2005;54:403-8.
10. Chang CC, Hung CH, Yen CS, Hwang KL, Lin CY. The relationship of plasma ghrelin level to energy regulation, feeding and left ventricular function in non-diabetic haemodialysis patients. Nephrol Dial Transplant 2005;20:2172-7.
11. Ukkola O, Ravussin E, Jacobson P, Perusse L, Rankinen T, Tschop M, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002;10:782-91.